Sepsis Diagnostics Market 2021 Research and Clinical Analysis - Abbott Laboratories Inc., Axis-Shield Diagnostics Ltd., Beckman Coulter, Inc, Becton, Dickinson, and Company

Global Sepsis Diagnostics Market Size and Forecast to 2021 – 2026 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data. The research analysts provide a detailed description of the value chain and its distributor analysis. This Market study provides comprehend Sepsis Diagnostics data that enhances the understanding, scope, and application of this report.

The study includes market share analysis and profiles of players such as Abbott Laboratories Inc., Axis-Shield Diagnostics Ltd., Beckman Coulter, Inc, Becton, Dickinson, and Company, BioMerieux SA, Bruker Corporation, Bruker Corporation, Cube Dx GmbH, Danaher Corporation, EKF Diagnostics, F. Hoffmann-LA Roche Ltd.

Click here to get a free sample copy of the latest research on Sepsis Diagnostics market (Flat 25% Off):

https://www.marketinsightsreports.com/reports/05202907432/sepsis-diagnostics-market-growth-trends-covid-19-impact-and-forecasts-2021-2026/inquiry?Mode=A28

Sepsis Diagnostics Market was valued at USD 550 million in 2020 and is expected to reach USD 975 million in 2026 by registering the CAGR of 9.8% during the forecast period.

Market Trends:

Molecular Diagnostics Segment by Technology is Expected to be Fastest Growing over the Forecast Period.

As per the Canadian Medical Association in December 2020, the most common complications associated with COVID-19 were pneumonia, respiratory failure, kidney failure, and sepsis or systemic inflammation, consistent with other studies. The absolute risk of someone with COVID-19 having sepsis was estimated to be approximately 10.4%. Researchers are making effort to develop a molecular diagnostic that can detect the COVID-19 as well as sepsis and also discriminate between the two. In November 2020, the Hellenic Institute for the Study of Sepsis and in part by Sanmina Corporation funded a study and developed a novel optical biosensor for the early diagnosis of sepsis and severe Covid-19. These developments are expected to have a positive impact on the growth of the market.

Sepsis affects significant patient populations in hospitals and is the sixth most common reason for hospitalization. Rapid and accurate profiling of infection-causing pathogens remains a significant challenge in modern healthcare. Finally, identification of the causative pathogen is essential in selecting appropriate antibiotic therapy as part of the treatment. These requirements make molecular diagnostics (MDx) an attractive approach to consider for sepsis diagnostics. Molecular diagnostics have attracted several multinational companies and institutions, owing to their easy feasibility and accuracy in detection methods. The blood culture analysis for rapid and accurate profiling of infections has been the gold standard for the molecular diagnostic method. However, the cost of molecular diagnostics has remained very high, as compared to conventional procedures, which restricts its market growth. Several companies are investing in point of care molecular diagnostics for early diagnosis of bacterial and viral pathogens and better patient management. For instance, in April 2019, GenMark Diagnostics, Inc. received the FDA clearance for its new panel assay, developed to detect gram-negative bacteria causing sepsis. The well-established healthcare infrastructure with high adoption of advanced diagnostic technologies and rising awareness for early disease diagnosis are expected to drive the growth of the market studied.

Market Segmentation:

By Types:

Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
Microfluidics
Biomarkers

By Applications:

Hospitals
Pathology & Reference Laboratories

Browse the report description and TOC:

https://www.marketinsightsreports.com/reports/05202907432/sepsis-diagnostics-market-growth-trends-covid-19-impact-and-forecasts-2021-2026?Mode=A28

Regional Analysis:

North America is Expected to Hold Largest Share of the Market

North America is found to hold a major share of the sepsis diagnostics market and is expected to show a similar trend over the forecast period, without significant fluctuations. According to the CDC statistics in 2018, sepsis affects more than a million Americans every year and leads to 15% to 30% deaths in the United States. Furthermore, the number of cases of sepsis is rising on a yearly basis in the country, due to factors, such as the rise in geriatric population, infections that are incurable by antibiotics, and higher risks of the disease among people who have undergone an organ transplant. The National Institutes of Health supports many studies that are focused on sepsis, which is evaluating various potential treatments for the disease. CDC launched the Get Ahead of Sepsis, which is an educational initiative to protect Americans from the effect of sepsis. This initiative calls on healthcare professionals to educate patients, prevent infections, identify and diagnose sepsis at an early stage, and start sepsis treatment fast. Emerging technologies linked with an enhanced understanding of the immature and developing neonatal immune system responses to early infection provide an opportunity to develop critically needed biomarkers to improve early identi?cation in this high-risk population. So, the increasing prevalence of sepsis, along with government initiative may augment the growth of the market studied.

The study objectives of this report are:

To study and analyze the global Sepsis Diagnostics size (value and volume) by the company, key regions/countries, products and application, history data from 2020 to 2025, and forecast to 2026.
To understand the structure of Sepsis Diagnostics by identifying its various sub-segments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Sepsis Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis, and development plans in the next few years.
To analyze the Sepsis Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Sepsis Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Purchase full Report@:

https://www.marketinsightsreports.com/report/purchase/05202907432?mode=su?Mode=A28

Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.